Drugs and receptors. An overview of the current state of knowledge.
about
Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.The effect of the beta(2) adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic functionIn Vitro and In Vivo Characterization of the Alkaloid NuciferineA Miniaturized Screen of a Schistosoma mansoni Serotonergic G Protein-Coupled Receptor Identifies Novel Classes of Parasite-Selective InhibitorsMediation by the same muscarinic receptor subtype of phasic and tonic contractile activities in the rat isolated portal veinPlasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions.Angiotensin converting enzyme binding sites in human heart and lung: comparison with rat tissuesComparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.GPCR functional selectivity has therapeutic impact.Dopamine receptor signaling and current and future antipsychotic drugs.Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373.Differences in the effects of NK1-receptor antagonists, (+/-)-CP 96,345 and CP 99,994, on agonist-induced responses in guinea-pig trachea.L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.Beta3-adrenoceptor function and long-term changes in body weight.SpasmolyticsThe Arg 389 Gly beta1-adrenergic receptor gene polymorphism and human fat cell lipolysis
P2860
Q24674289-58504944-E3A5-49C6-A6AC-7FF6C7A76708Q28367889-865FB634-326F-4E26-8A0C-64B1FE092C05Q28550683-40334F2B-54AC-4543-A742-DF724087AC2AQ28552148-E44FC718-32D8-47BE-ADB4-AAA46049E3AEQ28571547-7EBD8B6A-2869-4FD0-9A1F-BE26BEECF159Q34174259-C29E8C20-7FE0-423B-A305-9CDAD1A92C88Q35871055-82FE64C8-466A-45B5-BFE6-DD6CA3572DE7Q35874594-7AED14CB-78DE-4B73-AA97-92CF38BDF246Q36880909-6C46869C-3EFE-4AE2-B965-C0FA4507174AQ38058009-A06DAE73-71CD-4AA2-86F5-E0CF037B0C2FQ40221922-7F5A37E3-E24D-4681-B201-9721D9C6C529Q42017469-B88886D2-9C5B-4EA3-9A6D-B325DF9098CAQ42080582-F481C3E8-8A87-456B-9F15-C77D5F7E0265Q47188169-2C863FD5-F466-4838-A208-45D7CF1B27A7Q56554928-E7887738-C0AE-4B99-9913-DD7D6CCC729CQ57607771-1A8A56F2-C1B7-4F9D-BF36-D2E73A119058
P2860
Drugs and receptors. An overview of the current state of knowledge.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Drugs and receptors. An overview of the current state of knowledge.
@en
type
label
Drugs and receptors. An overview of the current state of knowledge.
@en
prefLabel
Drugs and receptors. An overview of the current state of knowledge.
@en
P1433
P1476
Drugs and receptors. An overview of the current state of knowledge.
@en
P2093
P304
P356
10.2165/00003495-199040050-00003
P577
1990-11-01T00:00:00Z
P6179
1028205212